<DOC>
	<DOCNO>NCT00808964</DOCNO>
	<brief_summary>This Phase 2 , multicenter , open-label , single-arm , sequential cohort study conduct 30 subject . The study evaluate subject undergoing primary , elective , off-pump CABG surgery median sternotomy .</brief_summary>
	<brief_title>Study NU172 Anticoagulation Patients Undergoing Off-pump CABG Surgery</brief_title>
	<detailed_description />
	<mesh_term>Heart Diseases</mesh_term>
	<criteria>Must give write informed consent prior initiation study relate procedure Male female subject least 18 year age Subject accept primary , elective offpump CABG surgery plan sternotomy without plan concomitant cardiac surgical procedure New York Heart Association ( NYHA ) Class III less heart failure Available followup assessment Prior surgery median sternotomy Prior CABG surgery Women childbearing potential use adequate contraceptive precaution ( e.g . intrauterine device , oral contraceptive , barrier method , contraception deem adequate investigator ) ; woman pregnant lactate Stroke within previous 6 month History stroke residual neurological deficit Intracranial neoplasm , arteriovenous malformation aneurysm Any prior exposure NU172 Contraindication unfractionated heparin Refusal undergo blood transfusion , necessary Symptomatic gout Serum uric acid &gt; 11mg/dL screen Known bleed diathesis Known thrombotic diathesis Participation study investigational device , drug biologic within 30 day prior plan surgery Any disease condition , judgment investigator would interfere subject 's ability comply study procedure requirement</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2011</verification_date>
	<keyword>CABG</keyword>
	<keyword>anticoagulant</keyword>
	<keyword>Off-Pump CABG</keyword>
</DOC>